European Commission's 2009 priorities address anticounterfeiting, legislative recast and Eudamed
This article was originally published in SRA
Executive Summary
The European Commission’s priorities for the medtech sector in 2009 include following up on a study on medical device counterfeiting and parallel trade that it conducted last year, and working on the recast of the medical device directives1,2.